These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 12014597)

  • 61. Treatment of ADHD with stimulant medications: response to Nissen perspective in the New England Journal of Medicine.
    Biederman J; Spencer TJ; Wilens TE; Prince JB; Faraone SV
    J Am Acad Child Adolesc Psychiatry; 2006 Oct; 45(10):1147-1150. PubMed ID: 16840880
    [No Abstract]   [Full Text] [Related]  

  • 62. Attention deficit hyperactive disorder: symptoms and treatment using stimulant medications.
    Finks K
    NASN Sch Nurse; 2012 Jan; 27(1):24-5. PubMed ID: 22720476
    [No Abstract]   [Full Text] [Related]  

  • 63. Stimulant therapy of 'adult hyperactivity'.
    Wender PH; Reimherr FW; Wood DR
    Arch Gen Psychiatry; 1985 Aug; 42(8):840. PubMed ID: 2861798
    [No Abstract]   [Full Text] [Related]  

  • 64. Effects of stimulant medication on growth rates across 3 years in the MTA follow-up.
    Swanson JM; Elliott GR; Greenhill LL; Wigal T; Arnold LE; Vitiello B; Hechtman L; Epstein JN; Pelham WE; Abikoff HB; Newcorn JH; Molina BSG; Hinshaw SP; Wells KC; Hoza B; Jensen PS; Gibbons RD; Hur K; Stehli A; Davies M; March JS; Conners CK; Caron M; Volkow ND
    J Am Acad Child Adolesc Psychiatry; 2007 Aug; 46(8):1015-1027. PubMed ID: 17667480
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Stimulant rebound: how common is it and what does it mean?
    Carlson GA; Kelly KL
    J Child Adolesc Psychopharmacol; 2003; 13(2):137-42. PubMed ID: 12880508
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Weeding Out the Justification for Marijuana Treatment in Patients with Developmental and Behavioral Conditions.
    Nelson T; Liu YH; Bagot KS; Stein MT
    J Dev Behav Pediatr; 2017; 38(6):446-448. PubMed ID: 28622159
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Getting an edge--use of stimulants and antidepressants in college.
    Kadison R
    N Engl J Med; 2005 Sep; 353(11):1089-91. PubMed ID: 16162878
    [No Abstract]   [Full Text] [Related]  

  • 68. Symptom Profiles, But Not Prefrontal Neurochemistry, Differentiate ADHD Youth With and Without a Family History of Bipolar I Disorder.
    Chen C; Tallman MJ; Cecil KM; Patino LR; Blom TJ; DelBello MP; McNamara RK
    J Atten Disord; 2022 Nov; 26(13):1762-1773. PubMed ID: 35658594
    [No Abstract]   [Full Text] [Related]  

  • 69. Adverse psychocutaneous effects of prescription stimulant use and abuse: A systematic review.
    Moattari CR; França K
    J Dtsch Dermatol Ges; 2022 Jan; 20(1):7-15. PubMed ID: 34990063
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Drugs for kids: good or bad?
    Albert PR
    J Psychiatry Neurosci; 2012 Sep; 37(5):293-5. PubMed ID: 22931683
    [No Abstract]   [Full Text] [Related]  

  • 71. Modafinil in poststroke depression.
    Berkowitz HL
    Psychosomatics; 2005; 46(1):93; author reply 93-4. PubMed ID: 15765833
    [No Abstract]   [Full Text] [Related]  

  • 72. Distinguishing ADHD from juvenile bipolar disorder: a guide for primary care PAs.
    Compton K; Taylor L; Carlozzi N; Fortson B; Bushardt RL; Askins DG; Barkley RA
    JAAPA; 2006 Dec; 19(12):41-2, 44, 46-8. PubMed ID: 17243260
    [No Abstract]   [Full Text] [Related]  

  • 73. Electrocardiogram before starting stimulant medications: to order or not?
    Aggarwal V; Aggarwal A; Khan D
    Cardiol Young; 2016 Jan; 26(1):216-9. PubMed ID: 26278960
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Late-onset attention-deficit/hyperactivity disorder as a differential diagnosis of dementia: a case report.
    Sasaki H; Jono T; Fukuhara R; Yuki S; Ishikawa T; Boku S; Takebayashi M
    BMC Psychiatry; 2020 Nov; 20(1):550. PubMed ID: 33228586
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Stimulant 'rapid metabolizers': wrong label, real phenomena.
    Weiss MD; Surman CBH; Elbe D
    Atten Defic Hyperact Disord; 2018 Jun; 10(2):113-118. PubMed ID: 29103196
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Cocaine abuse, attention deficit disorder, and bipolar disorder.
    Cocores JA; Patel MD; Gold MS; Pottash AC
    J Nerv Ment Dis; 1987 Jul; 175(7):431-2. PubMed ID: 3598571
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Takotsubo syndrome in bipolar affective disorder with alcohol withdrawal syndrome.
    Sidhu DS; Farrelly R; Lally J
    BMJ Case Rep; 2020 Oct; 13(10):. PubMed ID: 33130580
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Men and women from the STRIDE clinical trial: An assessment of stimulant abstinence symptom severity at residential treatment entry.
    Chartier KG; Sanchez K; Killeen TK; Burrow A; Carmody T; Greer TL; Trivedi MH
    Am J Addict; 2015 Jun; 24(4):336-40. PubMed ID: 25694201
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Treatment of attention problems with stimulant medication.
    Deuel RK
    J Pediatr; 1988 Jul; 113(1 Pt 1):68-71. PubMed ID: 3385531
    [No Abstract]   [Full Text] [Related]  

  • 80. Considering rationales for use in defining subgroups for the treatment of stimulant use disorder.
    Brooks O; Bach P; Hayashi K
    Drug Alcohol Depend; 2021 Apr; 221():108572. PubMed ID: 33593678
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.